Industry Briefing
A single destination for timely, editor-curated robotics news from around the world.
Enovis to Acquire eCential Robotics for Over $180 Million to Enhance Surgical Technology
Enovis Corp. has announced a binding offer to acquire eCential Robotics for approximately €155 million, exceeding $180 million. This acquisition aims to integrate eCential's modular surgical robotics platform into Enovis' ASTRA technology platform, enhancing its capabilities in orthopedic surgery. The addition of eCential's robotic technology is significant as it aligns with Enovis' strategy to provide surgeons with diverse technological options. CEO Damien McDonald emphasized that this move will strengthen their market position and expand strategic opportunities in robotic-assisted surgery, addressing evolving market demands. Looking ahead, Enovis plans to finalize the acquisition by the end of 2026, with an initial payment of €176 million and potential additional payments based on performance milestones. The integration of eCential's expertise is expected to accelerate the development of next-generation robotic solutions, particularly in knee and shoulder surgeries, within the next two years.
Financial Healthcare Robotics Markets / Industries Mergers & Acquisitions News Robots / Platforms
Enovis Acquires eCential Robotics for €155 Million to Enhance Surgical Orthopedic Robots
Enovis announced its acquisition of eCential Robotics for €155 million (approximately $180 million) to advance the development of surgical robots for orthopedic procedures. This strategic move aims to close a competitive gap and formalize an existing collaboration with eCential, which previously developed Johnson & Johnson's Velys Spine surgical robot. Enovis plans to launch a knee robot in late 2028 and a shoulder robot in 2029, enhancing its Astra enabling technology system with robotics capabilities. The acquisition is significant as it positions Enovis to compete more effectively in the orthopedic surgical robot market, where rivals like Johnson & Johnson and Stryker are already active. Enovis CEO Damien McDonald emphasized that integrating robotics technology is crucial for the company's long-term growth strategy. The planned knee and shoulder robots are expected to feature unique capabilities, including a robotic arm with seven degrees of freedom, setting them apart from existing offerings in the market. Looking ahead, Enovis aims to leverage eCential's expertise to accelerate product development and respond more effectively to clinician needs. The acquisition includes an upfront payment and potential milestone payments totaling up to €35 million, contingent on the successful development of the new devices. No further timeline was disclosed at the time of publication.
Robotics needs a service framework.
RSF defines a common language for robot service capability, lifecycle operations, certification pathways, and service-provider networks.
Join the RobotToday community on LinkedIn
Daily robotics news, in-depth analysis, conference highlights, and discussions with professionals worldwide.
